Pharmaceutical Technology on MSN19h
MSD secures worldwide license for LaNova’s LM-299MSD has secured an exclusive worldwide license from LaNova Medicines for developing, manufacturing, and commercialising the ...
Zacks.com on MSN10h
Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer TherapyMRK in-licenses a bispecific antibody, based on the same mechanism as SMMT's lead drug, which outperformed its blockbuster ...
GenScript Biotech, a global biotechnology leader in the life science, biologics manufacturing, synthetic biology, and cell ...
AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
VEGF bispecifics. | Merck and BioNTech are buying Chinese biotechs to gain PD-(L)1/VEGF bispecifics. AstraZeneca's CEO argued ...
America's Top 10 Real Estate News Where Real Estate Is Never Boring!"White House Replica Sells Before Election" Just days before the presidential election, a White House replica in Hillsborough, ...
Zacks.com on MSN10h
Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline SetbackThe third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY ...
Today Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization announced a campaign to secure a recommendation for T1D screening from the United ...
RAHWAY, NJ, USA I 14, 2024 I Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and LaNova Medicines Ltd. (LaNova), a privately ...
GlobalData on MSN20h
OMRON receives FDA authorisation for blood pressure monitors with AFib featureOMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback